Pfizer presents positive results in meningococcal disease late-stage trials
May 13, 2016Research and Development Pfizer, Vaccine, late stage trials, meningococcal disease
Pfizer (NYSE: PFE) has announced results from two pivotal late-stage trials demonstrating the immunogenicity of Trumenba against invasive meningococcal B …
Clinical Trials Equipment Supplier Woodley Equipment Exhibiting at Outsourcing in Clinical Trials East Coast 2016
May 13, 2016Woodley Equipment Company Limited is exhibiting at Outsourcing in Clinical Trials East Coast 2016. The event is taking place on …
Woodley Equipment Company Limited UK Office
May 13, 2016Woodley Equipment Company Limited UK Office
US pass new laws to combat opioid epidemic
May 13, 2016Medical Communications, Sales and Marketing US, epidemic, fight back, new laws, opioids, reverse
The US has passed new laws that will seek to combat the current epidemic of opioids across the country. The …
EU approves Idelvion for haemophilia B treatment
May 13, 2016Medical Communications, Research and Development CSL, EU, Idelvion, approval, haemophilia B
The European Commission has approved Idelvion, coagulation Factor IX (recombinant) for the treatment and prophylaxis of bleeding in patients with …
Sanofi Files Hart-Scott-Rodino notification for Medivation acquisition
May 13, 2016Medical Communications, Sales and Marketing M&A, MA, Medivation, Sanofi, deal
French drugmaker Sanofi (Euronext: SAN) on Friday said it has filed a premerger notification with the US Department of Justice Antitrust …
Sobi, Biogen’s haemophilia B therapy gets European approval
May 13, 2016Medical Communications, Research and Development, Sales and Marketing Biogen, haemophilia B, orphan designation, regulation, sobi
Sobi (STO: SOBI) and Biogen (Nasdaq: BIIB) on Friday said the European Commission has approved their drug to treat haemophilia B. The …
Bayer terminates clinical trial for hypertension due to safety concerns
May 13, 2016Medical Communications, Research and Development Bayer, clinical trial, deaths, pulmonary hypertension, riociguat, safety concerns
Bayer has terminated a Phase II trial evaluating riociguat in patients with pulmonary hypertension due to fears raised by an …
Takeda appoints new chief financial officer
May 12, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe
Takeda Pharmaceuticals has named James Kehoe its new chief financial officer. He will begin the role on June 15 2016, …
Almost 9 in 10 CCGs not implementing NICE guidelines on antibiotic resistance
May 12, 2016Research and Development, Sales and Marketing CCGs, NICE, antibiotic resistance, failure
The Patients Association has called on all Clinical Commissioning Groups (CCGs) to implement the National Institute for Health and Care …
BMS says Nice refuses backing for its immunotherapy Opdivo to treat lung cancer
May 12, 2016Medical Communications, Research and Development, Sales and Marketing
The National Institute for Health and Care Excellence (Nice) has rejected US pharma firm Bristol-Myers Squibb’s (NYSE: BMY) immune-oncology drug …
Multiple myeloma treatment from BMS and AbbVie scores EU approval
May 12, 2016Research and Development, Sales and Marketing AbbVie, BMS, EMA, EU, Empliciti, approval, bristl-myers squibb, elotuzumab, multiple myeloma
Bristol-Myers Squibb (NYSE: BMY) and AbbVie (NYSE: ABBV) have announced that the European Commission has approved Empliciti (elotuzumab) for the …
FDA issues warning about rare, but serious, side effect in Lilly antipsychotic drug
May 12, 2016Medical Communications, Sales and Marketing Eli Lilly, FDA, anti-psychotic, boxed warning, lilly, olanzapine, skin condition
The US Food and Drug Administration (FDA) has issued a new warning to all drug labels for Eli Lilly’s antipsychotic …
AstraZeneca says its trial drug for thyroid cancer granted US FDA orphan drug designation
May 12, 2016Research and Development, Sales and Marketing AstraZeneca, Orphan Drug Designation, US FDA, drug trial, regulation
AstraZeneca (LSE: AZN) on Thursday said the US Food and Drug Administration (FDA) has granted Orphan Drug Designation its trial …
Nice recommends two blood tests to rule out pre-eclampsia in pregnant women
May 11, 2016Medical Communications, Sales and Marketing NICE, Roche, regulation
The National Institute for Health and Care Excellence (Nice) has backed two blood tests to help rule-out a complication in …
Nice backs GSK’s lupus drug Benlysta
May 11, 2016Research and Development, Sales and Marketing GSK, NHS, NICE, regulation
The National Institute for Health and Care Excellence (Nice) has backed GlaxoSmithKline’s (LSE: GSK) Benlysta (belimumab) to treat lupus. The …
Gilead’s Sovaldi gets Indian patent; critics call it “major blow” to patient access
May 11, 2016Manufacturing and Production, Research and Development, Sales and Marketing India, harm, hepatitis, patent, patient access, sovaldi
Gilead has been granted a patent for its hepatitis C drug, Sovaldi (sofosbuvir), in India which has sparked dismay among …
Santen Pharmaceutical says eye allergy drug meets primary endpoints in Phase III trials
May 11, 2016Research and Development, Sales and Marketing Eye Allergy, Santen Pharmaceutical, drug trial, phase III
Santen Pharmaceutical said late stage trials for its drug to treat an allergic eye condition in children met its primary …
Allergan to buy back $10 billion of stock, Q1 earnings rise
May 11, 2016Research and Development, Sales and Marketing Allergan, Buy Back, Financial, Q1, earnings, results, revenue
Botox-maker Allergan (NYSE: AGN) said it plans to buy back as much as $10 billion in stock after completing the …
FDA expands Imbruvica label with new survival data
May 11, 2016Research and Development, Sales and Marketing AbbVie, FDA, Janssen, data, efficacy, expanded, imbruvica, label, late stage, phase III
The US Food and Drug Administration (FDA) has expanded the label of Imbruvica (ibrutinib) to include the data from recent …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
